echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > Br J Cancer: Socio-demographic differences in tumor stages and their effects on the population when diagnosed in 10 solid tumor patients

    Br J Cancer: Socio-demographic differences in tumor stages and their effects on the population when diagnosed in 10 solid tumor patients

    • Last Update: 2021-02-24
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Diagnosing patients with non-late stages of disease has become the main means of cancer prevention and control strategies, and is a supplement to cancer prevention and screening.
    , however, most cancer patients are diagnosed only after the onset of symptoms, due to the fact that only a few cancers can be effectively screened.
    , in addition to optimizing screening, public health policies in many countries focus on reducing the interval between onset and diagnosis of symptoms in order to reduce the number of people with advanced cancer.
    previous studies have shown that the stage of the disease at the time of diagnosis in cancer patients foreshadows survival, and understanding the relevant statistical differences can better guide disease interventions.
    adjustment advantage of late diagnosis distributed by age (30-99 years) in the stratum model of the tumor site is higher than the UK government's target of achieving TNM phase I/II for 75% of patients with common solid tumors by 2028.
    , however, how to achieve this goal, how to better improve the patient's TNM staging is still a challenge, and the strategy to help improve the distribution of tumor diagnosis in patients is to reduce the occurrence of socio-demographic differences.
    The study analyzed socio-demographic differences between Phase III/IV and Phase I/II by analyzing the diagnosis of 10 types of solid tumors (breast, bladder, colon, endometrial, lung, melanoma, prostate, rectal, kidney and ovarian).
    aims to study the diagnostic stages and associated socio-demographic variations of recent common cancers in the UK and to provide highly complete information on the stages of diagnosis in patients.
    results on the impact of eliminating age, gender and income inequality show that 57 per cent of the 202,001 cases were diagnosed with phase I/II (there is still a "gap" of 18 per cent compared to the 75 per cent target).
    although cancer sites were a major cause of these results, the researchers found that the likelihood of being diagnosed with stage III/IV increased with age, with prostate and endometrial cancer being the most significant.
    in all areas except lung and kidney cancer, the patient's financial income status is related to the stage at the time of diagnosis.
    four of these cancers show a gender imbalance.
    by eliminating socio-demographic inequalities, the researchers eventually analyzed that 61 percent of patients with 10 solid tumors were diagnosed with phase I/II, narrowing the target gap to 14 percent.
    , the results show that the potential elimination of socio-demographic inequalities can make a contribution to the achievement of phased goals.
    , the researchers suggest that early diagnostic strategies should focus on the entire population, not just the high-risk socio-demographic population.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.